NCT05456048
- Conditions
- Chromosome Aberrations, Cytogenetic Abnormality, Disease Attributes, +13 more
- Locations
-
- Department of Hematology,Nanfang Hospital, Southern Medical University Guangzhou, Guangdong, China
Clinical trial condition
Refractory Acute Myeloid Leukemia
Explore clinical trials studying Refractory Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.
100 public trials
42 recruiting studies
Refractory Acute Myeloid Leukemia trial results
NCT02551718
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT00426205
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +7 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02756572
- Conditions
- Blasts 10 Percent or More of Bone Marrow Nucleated Cells, Bone Marrow Diseases, Chronic Myelomonocytic Leukemia-2, +15 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Completed
Donor Natural Killer Cells in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01787474
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Decitabine With GCLAM for Adults With Newly Diagnosed, Relapsed, or Refractory AML or High-Risk MDS
NCT02921061
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
NCT02070458
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States
NCT01249430
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT01130506
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +10 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
- M D Anderson Cancer Center Houston, Texas, United States
Completed
Phase I Trial of Cabozantinib in Patients With Relapsed or Refractory Acute Myeloid Leukemia
NCT01961765
- Conditions
- Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Massachusetts General Hospital Boston, Massachusetts, United States